Vinícius Maciel Vilhena

Mr. Vinícius Maciel Vilhena

Laboratório de Pesquisa em Fármacos, Federal University of Amapá, Macapá, Amapá, Brazil
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in Nutraceuticals
Verified
Journal Article
Open access
PDF file
ANAline Lopes Do Nascimento
Aline Lopes Do Nascimento
GFGabriel da Costa Furtado
Gabriel da Costa Furtado
Vinícius Maciel VilhenaVinícius Maciel Vilhena
Vinícius Maciel Vilhena
Helison CarvalhoHelison Carvalho
Helison Carvalho
PSPRISCILA FAIMANN SALES
PRISCILA FAIMANN SALES
José Carlos Tavares CarvalhoJosé Carlos Tavares Carvalho
José Carlos Tavares Carvalho
The phytonutraceutical Ormona® is a product composed of purified oil of Bixa orellana Linné, dry extract of Myrciaria dubia McVaugh, dry extract of Trifolium pratense L., and dry extract of Euterpe oleracea Mart. obtained using Evolve® technology. This study evaluated the effects of Ormona® on Wistar rats affected by ovariectomy-induced osteoporosis. Pre-treatment was conducted for 15 days before surgery and continued for a further 45 days after the surgical procedure. The experimental design consisted of five groups (n = 5): OVW: treated with distilled water (1 mL/kg, p.o); ADS: alendronate sodium (4 mg/kg p.o); EST: conjugated estrogen (2 µg/kg, p.o); ORM: Ormona® (20 mg/kg, p.o); ORM + EST: Ormona® (20 mg/kg, p.o) + conjugated estrogen (2 µg/kg, p.o). Biochemical and hormonal parameters of bone histopathology and trabecular and femoral diaphysis size were evaluated through scanning electron microscopy (SEM) and bone calcium quantification by atomic absorption spectrophotometry. The results show that ovariectomy caused bone alterations such as loss of femoral microarchitecture, decreased bone homeostasis parameters, and changes in the lipid profile. Estrogen supplementation reduced parameters such as cholesterol, LDL, and Ca2+ concentration. However, Ormona® showed higher serum estradiol levels (p < 0.01), effects on the lipid profile, including parameters that estrogen replacement and alendronate sodium did not affect, with an increase in HDL, and positive modulation of bone metabolism, increasing osteocytes and the presence of osteoblasts. Ormona®, therefore, produced better results than the groups treated with estrogen and alendronate sodium.

1 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
LGLuciana Paes Gomes
Luciana Paes Gomes
NCNayara Nilcia Dias Colares
Nayara Nilcia Dias Colares
Helison CarvalhoHelison Carvalho
Helison Carvalho
BFBianca Vitória Monteiro Ferreira
Bianca Vitória Monteiro Ferreira
Vinícius Maciel VilhenaVinícius Maciel Vilhena
Vinícius Maciel Vilhena
José Carlos Tavares CarvalhoJosé Carlos Tavares Carvalho
José Carlos Tavares Carvalho
Medicinal plants hold great potential for the development of drugs to treat inflammatory diseases. Bixa orellana L, popularly known as “annatto” or “urucum”, stands out among various species. The Zebrafish (Danio rerio) is a small tropical freshwater fish which, due to its experimental attributes, has been highlighted as an experimental model in pharmacological and toxicological tests of new drugs. This study aims to evaluate the acute toxicological effects and anti-inflammatory activity of the injectable nanodispersion of Bixa orellana (NBO, Chronic In®) in zebrafish. The stability of the NBO was assessed with an average particle size ranging from 53.15 ± 0.64 nm to 59.90 ± 3.63 nm. The acute toxicity study used intraperitoneal doses of NBO ranging from 250 to 1500 mg/kg. The results showed significant toxic effects at doses of 750, 1000, and 1500 mg/kg with histopathological changes in the liver, kidneys, and intestine. The 50% lethal dose (LD50) calculation corresponded to 830.6 mg/kg. In silico tests suggest that the detected toxicity mechanism may be related to the inhibition of the cardiac potassium channel (hERG II) and/or the inhibition of the TNF tumor necrosis factor receptor-associated protein 1 (TRAP1). In the anti-inflammatory evaluation of NBO in a model of intraperitoneal edema induced by carrageenan in Zebrafish, a significant anti-inflammatory effect was observed at doses of 20 and 40 mg/kg (i.p), without significant histopathological alterations in the organs evaluated. In summary, NBO has an anti-inflammatory effect at low doses and demonstrated that doses of NBO ranging from 500 to 1500 mg/kg applied intraperitoneally were unsafe and showed toxic effects and lethality as the dose increased.

28 November 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
ANAline Lopes Do Nascimento
Aline Lopes Do Nascimento
GFGabriel da Costa Furtado
Gabriel da Costa Furtado
Vinícius Maciel VilhenaVinícius Maciel Vilhena
Vinícius Maciel Vilhena
HCHelison de Oliveira Carvalho
Helison de Oliveira Carvalho
PSPRISCILA FAIMANN SALES
PRISCILA FAIMANN SALES
José Carlos Tavares CarvalhoJosé Carlos Tavares Carvalho
José Carlos Tavares Carvalho
The phytonutraceutical Ormona® is a product composed of: purified oil of Bixa orellana Linné; dry extract of Myrciaria dubia McVaugh; dry extract of Trifolium pratense L. and dry extract of Euterpe oleracea Mart. obtained using Evolve® technology. This study evaluated the effects of Ormona® on Wistar rats affected by ovariectomy-induced osteoporosis. Pre-treatment was conducted for 15 days before surgery and continued for a further 45 days after the surgical procedure. The experimental design consisted of 5 groups (n=5): OVW: treated with distilled water (1 mL/ kg, p.o); ADS: alendronate sodium (4 mg/ kg p.o); EST: conjugated estrogen (2 ug/ kg, p.o); ORM: Ormona® (20 mg/kg, p.o); ORM + EST: Ormona® (20 mg/kg + conjugated estrogen 2 ug/ kg, p.o. Biochemical and hormonal parameters, along with bone histopathology and trabecular and femoral diaphysis size, were evaluated through Scanning Electron Microscopy (SEM) and bone calcium quantification by atomic absorption spectrophotometry. The results show that ovariectomy caused bone alterations such as loss of femoral microarchitecture, decreased bone homeostasis parameters, and changes in the lipid profile. Estrogen supplementation reduced parameters such as cholesterol, LDL, and Ca2+ concentration. However, Ormona® showed higher serum estradiol levels (p< 0.01), effects on the lipid profile, including parameters that estrogen replacement and alendronate sodium did not affect, with an increase in HDL, and positive modulation of bone metabolism, increasing osteocytes and the presence of osteoblasts. Ormona®, therefore, produced better results than the groups treated with estrogen and alendronate sodium.